Yeah this guy sounds like someone who is going to give it a fair shake:
"Dr Stephen Griffin at the University of Leeds said, "much like hydroxychloroquine before, there has been a considerable amount of off-label use of this drug," based mainly on studies of the virus in the lab, not in people.
"The danger with such off-label use is that...the use of the drug becomes driven by specific interest group or proponents of non-conventional treatments and becomes politicised," he said, adding this trial should provide a "final answer" to whether or not Ivermectin should be used to treat coronavirus."
So the "final answer" is going to come from a study structured by someone who wants it to fail.
For sure they'll mess up the clinical trial, since Pfizer plans on coming out with an antiviral pill at the end of the year.
Yeah this guy sounds like someone who is going to give it a fair shake:
"Dr Stephen Griffin at the University of Leeds said, "much like hydroxychloroquine before, there has been a considerable amount of off-label use of this drug," based mainly on studies of the virus in the lab, not in people.
"The danger with such off-label use is that...the use of the drug becomes driven by specific interest group or proponents of non-conventional treatments and becomes politicised," he said, adding this trial should provide a "final answer" to whether or not Ivermectin should be used to treat coronavirus."
So the "final answer" is going to come from a study structured by someone who wants it to fail.